» Articles » PMID: 20066092

The NF-kappaB Family of Transcription Factors and Its Regulation

Overview
Date 2010 Jan 13
PMID 20066092
Citations 1330
Authors
Affiliations
Soon will be listed here.
Abstract

Nuclear factor-kappaB (NF-kappaB) consists of a family of transcription factors that play critical roles in inflammation, immunity, cell proliferation, differentiation, and survival. Inducible NF-kappaB activation depends on phosphorylation-induced proteosomal degradation of the inhibitor of NF-kappaB proteins (IkappaBs), which retain inactive NF-kappaB dimers in the cytosol in unstimulated cells. The majority of the diverse signaling pathways that lead to NF-kappaB activation converge on the IkappaB kinase (IKK) complex, which is responsible for IkappaB phosphorylation and is essential for signal transduction to NF-kappaB. Additional regulation of NF-kappaB activity is achieved through various post-translational modifications of the core components of the NF-kappaB signaling pathways. In addition to cytosolic modifications of IKK and IkappaB proteins, as well as other pathway-specific mediators, the transcription factors are themselves extensively modified. Tremendous progress has been made over the last two decades in unraveling the elaborate regulatory networks that control the NF-kappaB response. This has made the NF-kappaB pathway a paradigm for understanding general principles of signal transduction and gene regulation.

Citing Articles

Impact of chromatin on HIV-1 latency: a multi-dimensional perspective.

Jones J, Gunderson C, Wigdahl B, Nonnemacher M Epigenetics Chromatin. 2025; 18(1):9.

PMID: 40055755 PMC: 11889793. DOI: 10.1186/s13072-025-00573-x.


Contribution of brain pericytes to neuroinflammation following repetitive head trauma.

Cembran A, Eisenbaum M, Paris D, Mullan M, Crawford F, Ferguson S J Inflamm (Lond). 2025; 22(1):11.

PMID: 40033399 PMC: 11877937. DOI: 10.1186/s12950-025-00439-9.


The alternative polyadenylation regulator CFIm25 promotes macrophage differentiation and activates the NF-κB pathway.

Mukherjee S, Barua A, Wang L, Tian B, Moore C Cell Commun Signal. 2025; 23(1):115.

PMID: 40022203 PMC: 11871739. DOI: 10.1186/s12964-025-02114-1.


Exploring the therapeutic promise of fisetin: molecular mechanisms and clinical aspects in lung cancer.

Goyal K, Babu M, Afzal M, Rekha A, Ali H, Gupta S J Complement Integr Med. 2025; .

PMID: 40013371 DOI: 10.1515/jcim-2024-0444.


Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies.

Pouyan A, Ghorbanlo M, Eslami M, Jahanshahi M, Ziaei E, Salami A Mol Cancer. 2025; 24(1):58.

PMID: 40011944 PMC: 11863469. DOI: 10.1186/s12943-025-02267-0.


References
1.
Malek S, Huang D, Huxford T, Ghosh S, Ghosh G . X-ray crystal structure of an IkappaBbeta x NF-kappaB p65 homodimer complex. J Biol Chem. 2003; 278(25):23094-100. DOI: 10.1074/jbc.M301022200. View

2.
Courtois G, Gilmore T . Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene. 2006; 25(51):6831-43. DOI: 10.1038/sj.onc.1209939. View

3.
Inoue J, Kerr L, Kakizuka A, Verma I . I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family. Cell. 1992; 68(6):1109-20. DOI: 10.1016/0092-8674(92)90082-n. View

4.
Lin L, DeMartino G, Greene W . Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell. 1998; 92(6):819-28. DOI: 10.1016/s0092-8674(00)81409-9. View

5.
Naumann M, Scheidereit C . Activation of NF-kappa B in vivo is regulated by multiple phosphorylations. EMBO J. 1994; 13(19):4597-607. PMC: 395392. DOI: 10.1002/j.1460-2075.1994.tb06781.x. View